Hangzhou Tigermed Consulting Co., Ltd (HKG:3347)
Hong Kong · Delayed Price · Currency is HKD 38.60
+0.24 (0.63%)
At close: Dec 5, 2025
HKG:3347 Market Cap
HKG:3347 has a market cap or net worth of 44.61 billion as of December 5, 2025. Its market cap has decreased by -24.59% in one year.
Market Cap
44.61B
Enterprise Value
48.54B
Revenue
7.17B
Ranking
n/a
PE Ratio
66.68
Stock Price
38.60
Market Cap Chart
Since August 17, 2012, HKG:3347's market cap has increased from 2.44B to 44.61B, an increase of 1,728.78%. That is a compound annual growth rate of 24.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 44.61B | -4.47% |
| Dec 31, 2024 | 46.70B | -5.40% |
| Dec 29, 2023 | 49.36B | -50.14% |
| Dec 30, 2022 | 98.99B | -22.60% |
| Dec 31, 2021 | 127.90B | -22.92% |
| Dec 31, 2020 | 165.93B | 213.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 285.39B |
| Hansoh Pharmaceutical Group Company | 253.90B |
| JD Health International | 192.73B |
| Innovent Biologics | 157.67B |
| WuXi Biologics | 134.32B |
| Sino Biopharmaceutical | 122.28B |
| Akeso | 114.31B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |